Why is Remus Pharma. falling/rising?

As of 07-Aug, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 849.05, which reflects a decrease of Rs. 25.9 or 2.96%. The stock has hit a new 52-week low of Rs. 834.95 today and has underperformed its sector by 3.61%. It has been on a consecutive downward trend for the last three days, resulting in a total decline of 5.66% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. There has also been a significant drop in investor participation, with delivery volume falling by 71.01% compared to the 5-day average, contributing to the stock's poor performance. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's movement.
In the broader market context, Remus Pharmaceuticals has underperformed relative to the Sensex, with a 1-week return of -7.76% compared to the benchmark's -0.70%. Over the past month, the stock has declined by 6.61%, while the Sensex has only fallen by 3.40%. Year-to-date, Remus Pharmaceuticals has seen a significant drop of 32.01%, contrasting sharply with the Sensex's gain of 4.02%. This stark difference in performance highlights the challenges faced by Remus Pharmaceuticals in the current market environment.